Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Seamlessly bridge your LNP discovery journey from RUO to bulk GLP-tox and GMP excipient-grade material.
Explore CGMP Lipid ServicesLipid TG4C is an ionizable cationic glycerolipid (pKa = 6.71) that has been used in the generation of lipid nanoparticles (LNPs) for the delivery of mRNA in vivo.1 LNPs containing lipid TG4C and encapsulating mRNA encoding human erythropoietin (EPO) increase serum EPO levels in mice. Nebulized administration of LNPs containing lipid TG4C and encapsulating mRNA encoding human hepatocyte growth factor (HGF) reduces bronchoalveolar lavage fluid (BALF) levels of Il-1β, Il-6, and Tnf-α in a mouse model of pulmonary emphysema induced by porcine pancreatic elastase.
WARNING This product is not for human or veterinary use.
1. Nebulized lipid nanoparticles based on degradable ionizable glycerolipid for potent pulmonary mRNA delivery. ACS Nano 19(1), 1128-1139 (2025).